Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Assets (2022 - 2026)

Updated

Adlai Nortye's Assets came in at $248.36 million for Q2 2026, up 244.7% from $72.05 million a year earlier.

Analysis

Adlai Nortye (ANL) Assets (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye's Assets was $34.43 million, down 51.7% from FY2024.

  • Assets carries a three-year compound annual growth rate of -22.0% (FY2022 to FY2025).
  • Going back by year, Assets was $71.27 million in FY2024 (-45.3%), $130.19 million in FY2023 (+79.3%) and $72.59 million in FY2022.
  • Year-over-year, Assets increased in 1 of the last four quarters, with growth averaging 28.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Adlai Nortye 528.79 Mn 429.49 Mn - 248.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 248.36 Mn
Dec 31, 2025 34.43 Mn
Jun 30, 2025 72.05 Mn
Dec 31, 2024 71.27 Mn
Jun 30, 2024 107.68 Mn
Dec 31, 2023 130.19 Mn
Dec 31, 2022 72.59 Mn
API Access

Adlai Nortye Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ANL&period=max&api_key=YOUR_API_KEY